Vascular Aging: Moving from Bench Towards Bedside 

EVA plays a key role in cardiovascular risk assessment, as it involves changes in arterial structure and function over time, leading to increased cardiovascular risk A review conducted by Climie and her team focus on lifestyle changes, pharmacological treatments, and therapies targeting arterial function which can be integrated into clinical treatment to reduce EVA. They identify that vascular biomarkers from waveform analysis can help predict cardiovascular events and improve risk re-classification, especially in special populations. The importance of early identification of accelerated vascular ageing for cardiovascular prevention is highlighted, with potential benefits for patient adherence and outcomes.